Ignite Creation Date:
2025-12-25 @ 5:02 AM
Ignite Modification Date:
2026-01-24 @ 3:56 AM
Study NCT ID:
NCT04776018
Status:
TERMINATED
Last Update Posted:
2024-10-02
First Post:
2021-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM)
Sponsor:
Takeda
Organization: